Company profile: Navitas Life Sciences
1.1 - Company Overview
Company description
- Provider of services for Finbrin Split products and data science and supply chain solutions for large pharma, leveraging expert teams from TAKE Life Sciences and WCI Consulting and specialists in clinical development, regulatory, technology, and consulting to deliver client insights.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Navitas Life Sciences
hVIVO
HQ: Ireland
Website
- Description: Provider of niche CRO pharmaceutical services specializing in human challenge clinical trials to test vaccines and antivirals for infectious and respiratory diseases, operating Europe’s only 24-bedroom quarantine clinic with onsite virology. Offers clinical trial design and execution, lab assays, and tech-enabled volunteer recruitment (including FluCamp), alongside ESG initiatives.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full hVIVO company profile →
Velocity Clinical Research
HQ: United States
Website
- Description: Provider of clinical trial management; patient recruitment and retention; and in-house laboratory services to deliver high-quality clinical trial data. Offers technology solutions (VISION Recruit, VISION Engage) to streamline clinical trial processes and improve patient experiences, consumer product safety and efficacy testing, and sustainability initiatives to reduce environmental impact.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Velocity Clinical Research company profile →
Icagen
HQ: United States
Website
- Description: Provider of ion channel-focused drug discovery platforms and services, including the Ion Channel Technology combining novel reagent generation, advanced biophysical analysis, and in silico tools; discovery-to-lead optimization services; and partnering with pharma/biotech to advance orally administered small-molecule therapeutics in neuroscience and chronic kidney disease.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Icagen company profile →
Ritedose
HQ: United States
Website
- Description: Provider of pharmaceutical products and services focused on the respiratory market. A leader in blow-fill-seal (BFS) manufacturing of small-fill unit dose sterile and non-sterile liquids for inhalation and ophthalmic use. Offers 503B outsourcing with pre-filled, ready-to-use syringes for hospitals and generic inhalation solutions including cromolyn sodium, albuterol sulfate, and arformoterol tartrate.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ritedose company profile →
Wacker Chemie
HQ: Germany
Website
- Description: Provider of silicone products (emulsions, rubber, silica) for electronics and automotive; polymer solutions for construction, adhesives and coatings; high-purity polysilicon for semiconductor and solar; biotechnology products and services including biopharmaceuticals and food ingredients; plus technical competence centers offering expert advice and product development support.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Wacker Chemie company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Navitas Life Sciences
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Navitas Life Sciences
2.2 - Growth funds investing in similar companies to Navitas Life Sciences
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Navitas Life Sciences
4.2 - Public trading comparable groups for Navitas Life Sciences
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →